Kaitlin J Mayne

16PUBLICATIONS
67CO-AUTHORS
Clinical pharmacy and pharmacy practiceRespiratory diseasesMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)Nephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 30, 2025
"Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.

Kaitlin J Mayne, William G Herrington

|Oct 24, 2025
Increased risk of cardiac death with cumulative exposure to fluid overload and dialysate sodium ≤138 mmol/l in hemodialysis patients.

Martin Christa, Brendan Smyth, Kaitlin J Mayne

|Aug 19, 2025
Cardiovascular-kidney-metabolic syndrome and mortality in a prospective UK cohort study.

Kaitlin J Mayne, Heather Walker, Benjamin M P Elyan

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Nov 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Parminder K Judge, Katherine R Tuttle, Natalie Staplin

|Nov 08, 2024
Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis.

Jule Pinter, Bernard Canaud, Kaitlin J Mayne

Pageof 3

Frequent Collaborators

6 joint publications

William G Herrington

5 joint publications

Richard Haynes

5 joint publications

Christoph Wanner

4 joint publications

Jennifer S Lees